CKD Bio Corp. (KRX:063160)

CKD Bio Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-23,130	-16,703	-6,577	6,207	12,265	7,956
Depreciation & Amortization	17,661	17,938	16,984	12,235	9,777	8,956
Loss (Gain) From Sale of Assets	-180.73	-11.15	-42.64	-1.54	41.71	-95.81
Loss (Gain) From Sale of Investments	776.65	-0.18	0.97	1.59	-18.51	148.26
Provision & Write-off of Bad Debts	-	-	-	-125.87	-	-
Other Operating Activities	21.09	9,509	-2,733	-1,001	6,444	2,647
Change in Accounts Receivable	-14,382	1,783	-5,083	16,278	-11,612	-2,293
Change in Inventory	2,383	-13,183	-10,811	-26,871	-3,100	4,835
Change in Accounts Payable	1,182	-1,659	2,117	788.59	1,256	-3,940
Change in Other Net Operating Assets	-918.51	-878.17	261.98	-2,688	1,937	-2,678
Operating Cash Flow	-16,588	-3,205	-5,882	4,824	16,990	15,536
Operating Cash Flow Growth	-	-	-	-71.61%	9.36%	-32.16%

Investing Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Capital Expenditures	-6,242	-6,200	-20,486	-61,659	-47,314	-16,396
Sale of Property, Plant & Equipment	20.43	32.96	43.3	1.55	44.94	96.38
Sale (Purchase) of Intangibles	-2,525	-1,031	-219.63	-950.5	-492.75	-615.91
Investment in Securities	-5,777	-10,000	-	3	4,803	1,043
Other Investing Activities	594.84	-3,349	274.8	2.15	-1,388	-268
Investing Cash Flow	-13,929	-20,547	-20,388	-62,602	-44,348	-16,141

Financing Activities

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Short-Term Debt Issued	-	62,950	38,222	86,211	12,732	2,832
Long-Term Debt Issued	-	-	36,421	44,200	17,000	2,000
Total Debt Issued	125,099	62,950	74,643	130,411	29,732	4,832
Short-Term Debt Repaid	-	-30,294	-44,547	-74,353	-8,132	-5,851
Long-Term Debt Repaid	-	-7,148	-726.97	-4,673	-658.72	-56.4
Total Debt Repaid	-87,854	-37,442	-45,274	-79,026	-8,790	-5,907
Net Debt Issued (Repaid)	37,245	25,508	29,369	51,385	20,941	-1,075
Issuance of Common Stock	-	-	-	4,453	-	-
Repurchase of Common Stock	-	-	-	-58.86	-	-
Dividends Paid	-	-548.6	-1,097	-1,026	-1,026	-2,052
Other Financing Activities	-0	-0	-0	0	0	-
Financing Cash Flow	37,245	24,959	28,272	54,753	19,915	-3,126

Net Cash Flow

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Foreign Exchange Rate Adjustments	-26.28	-18.74	-0.01	-3.86	-15.67	-20.22
Miscellaneous Cash Flow Adjustments	-	-	-	-	-	-0
Net Cash Flow	6,702	1,189	2,003	-3,029	-7,458	-3,752

Free Cash Flow

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Free Cash Flow	-22,830	-9,404	-26,368	-56,835	-30,324	-860.71
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Margin	-14.27%	-6.03%	-18.54%	-45.61%	-22.11%	-0.69%
Free Cash Flow Per Share	-4161.70	-1714.22	-4806.49	-10504.67	-5630.22	-159.81
Levered Free Cash Flow	-15,080	-10,022	-27,906	-68,119	-26,406	-
Unlevered Free Cash Flow	-12,227	-8,185	-26,697	-67,726	-26,310	-

Additional Metrics

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash Interest Paid	4,361	2,668	1,844	1,051	79.46	120.06
Cash Income Tax Paid	-	452.67	-72.74	3,296	1,292	1,016
Change in Working Capital	-11,736	-13,938	-13,515	-12,491	-11,518	-4,076

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2023

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error